Infimycin® Powder for IV

Indication : Azithromycin IV is indicated for the treatment of Community Acquired Pneumonia (CAP) caused by susceptible organisms, including Legionella pneumophila, in patients who required initial IV therapy.
In combination with Metronidazole, Azithromycin IV is indicated for the treatment of Pelvic Inflammatory Disease (PID) caused by susceptible organisms, in patients who require initial IV therapy

Composition : Each vial Infimycin® Powder for IV infusion 0.5 g contains Azithromycin dihydrate sterile buffered sodium citrate lyophilized equivalent to Azithromycin 0.5 g

Presentation : Infimycin® Powder for IV infusion 0.5 g
Box, 1 vial @ 0,5 g

On medical prescription only.
Store below 30°C.
Stable reconstitution solution within 24 hours when stored below 30°C. When reconstituted as directed, chemical and physical solubility stable for 24 hours under the temperature of 30°C or for 7 days if stored at refrigerator temperature (2 – 8)°C.